Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Porokeratosis | 2 | 2018 | 2 | 1.220 |
Why?
|
| Penis | 2 | 2018 | 16 | 1.200 |
Why?
|
| Skin | 3 | 2022 | 140 | 0.650 |
Why?
|
| Pityriasis | 1 | 2019 | 1 | 0.650 |
Why?
|
| Hair Diseases | 1 | 2019 | 5 | 0.640 |
Why?
|
| Multiple Myeloma | 1 | 2019 | 27 | 0.630 |
Why?
|
| Bone Marrow Transplantation | 1 | 2019 | 42 | 0.630 |
Why?
|
| Skin Cream | 1 | 2018 | 1 | 0.630 |
Why?
|
| Emollients | 1 | 2018 | 2 | 0.620 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2018 | 8 | 0.620 |
Why?
|
| Desmoplakins | 1 | 2018 | 4 | 0.620 |
Why?
|
| HIV Seropositivity | 1 | 2018 | 11 | 0.610 |
Why?
|
| Buttocks | 1 | 2018 | 6 | 0.610 |
Why?
|
| Scrotum | 1 | 2018 | 8 | 0.610 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2018 | 37 | 0.600 |
Why?
|
| Skin Neoplasms | 3 | 2024 | 128 | 0.590 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 104 | 0.580 |
Why?
|
| Isotretinoin | 1 | 2016 | 2 | 0.530 |
Why?
|
| Acne Vulgaris | 1 | 2016 | 6 | 0.530 |
Why?
|
| Dermatologic Agents | 1 | 2016 | 3 | 0.530 |
Why?
|
| Cystic Fibrosis | 1 | 2016 | 32 | 0.510 |
Why?
|
| Carcinoma, Basal Cell | 3 | 2024 | 12 | 0.490 |
Why?
|
| Male | 11 | 2024 | 12871 | 0.340 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 367 | 0.310 |
Why?
|
| Humans | 14 | 2024 | 26842 | 0.290 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2024 | 152 | 0.250 |
Why?
|
| Aged | 5 | 2024 | 5166 | 0.240 |
Why?
|
| Ear, External | 1 | 2023 | 11 | 0.220 |
Why?
|
| Female | 8 | 2024 | 14462 | 0.220 |
Why?
|
| Middle Aged | 5 | 2024 | 6818 | 0.210 |
Why?
|
| Biopsy | 2 | 2024 | 199 | 0.200 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 1926 | 0.190 |
Why?
|
| Prunus dulcis | 1 | 2021 | 1 | 0.190 |
Why?
|
| Muir-Torre Syndrome | 1 | 2021 | 1 | 0.190 |
Why?
|
| Skin Aging | 1 | 2021 | 8 | 0.190 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 19 | 0.180 |
Why?
|
| Cephalexin | 1 | 2018 | 1 | 0.160 |
Why?
|
| Water Loss, Insensible | 1 | 2018 | 3 | 0.160 |
Why?
|
| Doxycycline | 1 | 2018 | 19 | 0.160 |
Why?
|
| Epidermis | 1 | 2018 | 11 | 0.160 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2018 | 3 | 0.160 |
Why?
|
| Suture Techniques | 1 | 2018 | 28 | 0.150 |
Why?
|
| Keratoderma, Palmoplantar | 1 | 2018 | 1 | 0.150 |
Why?
|
| Nails, Malformed | 1 | 2018 | 1 | 0.150 |
Why?
|
| Foot | 1 | 2018 | 21 | 0.150 |
Why?
|
| Mycophenolic Acid | 1 | 2018 | 16 | 0.150 |
Why?
|
| Mohs Surgery | 3 | 2024 | 15 | 0.150 |
Why?
|
| Alopecia | 1 | 2018 | 5 | 0.150 |
Why?
|
| Skin Abnormalities | 1 | 2018 | 5 | 0.150 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2018 | 14 | 0.150 |
Why?
|
| Urethra | 1 | 2018 | 33 | 0.150 |
Why?
|
| Leg | 1 | 2018 | 131 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 110 | 0.140 |
Why?
|
| Incidence | 1 | 2018 | 545 | 0.140 |
Why?
|
| Treatment Outcome | 2 | 2024 | 2264 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2024 | 1216 | 0.130 |
Why?
|
| Phenotype | 1 | 2018 | 667 | 0.130 |
Why?
|
| Administration, Oral | 1 | 2016 | 166 | 0.130 |
Why?
|
| Infant | 1 | 2018 | 957 | 0.120 |
Why?
|
| Mutation | 1 | 2018 | 820 | 0.110 |
Why?
|
| Child | 2 | 2018 | 2146 | 0.110 |
Why?
|
| Adult | 3 | 2024 | 7382 | 0.110 |
Why?
|
| Orphanages | 1 | 2012 | 1 | 0.100 |
Why?
|
| Anemia | 1 | 2012 | 41 | 0.100 |
Why?
|
| Nutritional Status | 1 | 2012 | 73 | 0.100 |
Why?
|
| Retrospective Studies | 1 | 2018 | 2432 | 0.100 |
Why?
|
| Child Development | 1 | 2012 | 71 | 0.090 |
Why?
|
| Adolescent | 2 | 2016 | 2957 | 0.090 |
Why?
|
| HIV Infections | 1 | 2012 | 146 | 0.090 |
Why?
|
| Young Adult | 1 | 2016 | 2582 | 0.080 |
Why?
|
| Frozen Sections | 1 | 2024 | 4 | 0.060 |
Why?
|
| Uncertainty | 1 | 2024 | 23 | 0.060 |
Why?
|
| Physical Examination | 1 | 2024 | 47 | 0.060 |
Why?
|
| Clinical Decision-Making | 1 | 2024 | 61 | 0.060 |
Why?
|
| Skin Pigmentation | 1 | 2024 | 10 | 0.060 |
Why?
|
| Cartilage | 1 | 2023 | 33 | 0.050 |
Why?
|
| Private Practice | 1 | 2022 | 8 | 0.050 |
Why?
|
| Erythema | 1 | 2021 | 4 | 0.050 |
Why?
|
| Chin | 1 | 2021 | 5 | 0.050 |
Why?
|
| Neck | 1 | 2021 | 25 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2021 | 41 | 0.050 |
Why?
|
| United States | 1 | 2024 | 2031 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2012 | 13 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2012 | 17 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2012 | 15 | 0.030 |
Why?
|
| Malnutrition | 1 | 2012 | 30 | 0.030 |
Why?
|
| India | 1 | 2012 | 137 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 400 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2012 | 1090 | 0.020 |
Why?
|